Introduction
For many years, access to contraception has been a hotly debated topic in the United States. Recently, the possibility of over-the-counter (OTC) contraception has been in the news, with advocates suggesting that it could increase access to birth control and decrease unintended pregnancies. In this article, we will discuss the current state of OTC contraception in the US and what it could mean for American women.
What is OTC Contraception?
OTC contraception refers to birth control that can be purchased without a prescription from a healthcare provider. In other countries, such as the United Kingdom, some forms of contraception, such as the pill, are available over the counter.
Current State of OTC Contraception in the US
Currently, there are no forms of contraception that are available over the counter in the United States. However, some types of emergency contraception, such as Plan B, are available without a prescription for women ages 18 and older. Additionally, some states have passed laws allowing pharmacists to prescribe and dispense hormonal contraception, such as the pill.
Pros and Cons of OTC Contraception
There are several potential benefits and drawbacks to making contraception available over the counter:
Pros:
– Increased access: Making contraception available without a prescription could increase access to birth control for women who have difficulty obtaining a prescription or accessing healthcare.
– Reduced cost: Eliminating the need for a prescription could reduce the costs associated with obtaining birth control.
– Decreased unintended pregnancies: Increased access to contraception could reduce unintended pregnancies and decrease the need for abortion.
Cons:
– Lack of medical supervision: Without a healthcare provider prescribing and monitoring use of birth control, some women may not receive appropriate health screenings or counseling related to contraception.
– Reduced insurance coverage: Insurance coverage for contraception may be more limited if it is available over the counter, which could lead to increased out-of-pocket costs for some women.
– Increased risk of side effects: Without proper medical supervision, some women may not be aware of potential side effects or interactions with other medications they are taking.
Potential Impact on American Women
If OTC contraception is approved in the United States, it could have a significant impact on American women. It could increase access to birth control and decrease unintended pregnancies, which could have positive effects on women’s health and well-being. However, it is important to ensure that women still have access to healthcare providers for counseling and screening related to contraception use.
Conclusion
While the possibility of OTC contraception is exciting for many advocates, it is important to approach this topic with caution and consideration for all potential impacts on women’s health and access to healthcare. As always, it is important for women to discuss their contraceptive options with a healthcare provider, regardless of whether the method is available over the counter or requires a prescription.
68 percent of women in America who are having unprotected sex say that they would be able to get birth control if they didn’t have to first obtain a doctor’s prescription. While hormonal birth control pills are substantially safer than many types of over the counter medication, obstetricians and gynecologists have tended to lobby for it to remain presciption-only, for both economic and safety reasons.
However, that may all be changing in the near future. The American College of Obstetricians and Gynecologists (ACOG), the biggest organization in the U.S. for doctors involved in women’s reproductive healthcare, now says that it approves over the counter access for some types of hormonal birth control.
Safety concerns have always been the primary reason that doctors and health departments in the past have shied away from letting any woman purchase the Pill at her local pharmacy. Of particular concern to many physicians is the possibility of pulmonary embolism, which can be deadly.
However, the ACOG Committee Opinion about OTC birth control access shows some startling figures: while there is indeed a risk involved with taking birth control pills, the risk of pulmonary embolism is much higher during labor and the post-partum period. ACOG notes that several other very commonly ingested over the counter medications, like acetaminophen (Tylenol), have substantially worse side effect profiles including permanent liver damage. These side effects are a much more common than significant side effects from birth control pills.
One of the advantages that the ACOG sees in allowing over the counter access to birth control pills is that this allows women to buy several packs at once. It’s much more likely for women, especially young women, to continue using birth control when they have access to several packs at once. ACOG reports that their trials show significantly higher continuation rates for women who receive 7 pill packs than those who receive three.
Until recently, one of the biggest reasons that obstetricians were reluctant to throw their support behind over the counter birth control was that birth control prescriptions brought women to the doctor for preventative care like Pap smears when they otherwise may not have done so. However, ACOG says that this is not a sufficient reason to withhold oral contraceptives, because this examination is in no way relevant to starting a regimen of birth control pills.
With Obamacare now helping women to obtain free birth control from their insurance providers, the new recommendations may actually cost insured women more, while costing uninsured women substantially less, if they are enacted. However, the greater ease of access to birth control may make it so that many more women can use reliable contraceptive methods without worrying about the cost of a doctor visit or the embarrassment of invasive examinations simply to get contraception.
In order for birth control to be made over the counter in the United States, a drug company would have to propose making a particular birth control formulation available for OTC sales. The FDA would then have to review all the evidence about that formulation before making a final determination on whether to allow over the counter sales.
Source: acog.org
